Nasopharyngeal chordoma in a patient with a severe form of sleep-disordered breathing: A case report

Introduction

Sleep-disordered breathing (SDB) describes a group of disorders that are characterized by breathing difficulties while sleeping. Examples of SDB include primary snoring, upper airway resistance syndrome and obstructive sleep apnea (OSA). SDB is characterized by repeated narrowing of the upper airway during sleep, which leads to partial or complete obstruction of the airways (1,2). The symptoms of SDB are dependent on the time of day; symptoms experienced at night include choking, pauses in breathing and nocturia, whereas day time symptoms include fatigue, extreme tiredness and a depressed mood (3). A number of predisposing factors have been identified, such as age (>40 years), obesity, recent weight gain, male gender, alcohol consumption, nasal blockage and maxillo-mandibular abnormalities (1).

Nasopharyngeal organic lesions, particularly malignant neoplasms, are a rare cause of SDB in adults. Chordomas are histologically benign but clinically malignant axial skeleton neoplasms that represent 0.1–0.2% of all intracranial neoplasms, 6–16% of skull base neoplasms and 1–4% of primary malignant bone tumors (4,5). Furthermore, approximately one-third of all chordomas are located within the skull base (6,7). The slow growth of chordomas and a lack of specific initial symptoms may prevent the diagnosis of the neoplasm, thus resulting in an extended period of tumor development. Clinically, with the exception of nasal patency disorders, chordoma symptoms may include headaches, diplopia, swallowing disorders, Eustachian tube patency disorders, tinnitus and secretion retention in the nasal cavity. The subtle onset and benign macroscopic image of the tumor (similar to an enlarged adenoid) may result in diagnostic errors.

The current study presents a case of incidentally diagnosed nasopharyngeal chordoma that manifested as a patency disorder in the upper airways and was the predominant cause of a severe form of SDB. Written informed consent was obtained from the patient.

Case report

The current study presents the case of a 32-year-old female patient, with a severe form of SDB caused by the presence of a nasopharyngeal tumor impairing nasal breathing. The patient was diagnosed with SDB at the Department of Otorhinolaryngology at the English Dentistry Division of the Medical University of Warsaw (Warsaw, Poland) during the course of a research program investigating a group of pathologically obese patients who qualified for bariatric surgery.

In accordance with the research program's assumptions, each patient routinely completed an interview, and underwent a laryngological physical examination, upper airway endoscopy, anterior rhinomanometry, computed tomography (CT) scan of the maxillofacial region and a full in-laboratory polysomnography. The present patient was diagnosed with third-degree obesity, with a body mass index (BMI) of 41.9 kg/m2 (height, 1.62 meters; body weight, 110 kg). During the interview, a five-year history of nasal patency disorders was noted. The laryngological examination revealed a left-sided deviation of the nasal septum to a limited degree and moderate hypertrophy of the tonsils. The isthmus of the pharynx was not significantly narrowed, however, an upper airway endoscopy revealed a soft-tissue mass with a smooth surface located within the nasopharynx, which caused almost complete impaired patency. Significant nasopharyngeal obstruction prevented an objective assessment of nasal ventilation with the use of anterior rhinomanometry. CT of maxillofacial region was consistent with the nasopharynx being filled with soft tissue and did not reveal features of destruction within the sphenoid bone (Fig. 1A and B).

Figure 1. (A and B) Pre-operative computed tomography (CT) scan of the maxillofacial region. Soft tissue filling the nasopharynx was observed, but no evidence of sphenoid bone destruction was present. (C) Post-operative CT of the maxillofacial region with contrast demonstrating thickening of the posterior pharyngeal wall, but with no evidence of bone infiltration. (D) Post-operative magnetic resonance imaging examination indicating a contrast-enhanced pathological mass at the nasopharyngeal roof.

A complete polysomnography, including electroencephalography, electrooculography and electromyography, was performed to assess the sleep structure of the patient. An assessment of respiratory function was performed by recording chest and abdomen respiratory movements, nasal and mouth air passage and continuous arterial blood oxygen saturation levels. In addition, continuous electrocardiogram records were kept. In the course of the polysomnography study, the patient exhibited 392 incidents of SDB (five obstructive, 19 central and 16 mixed apneas, and 352 hypopneas) resulting in an apnea hypopnea index (AHI) of 53.5. Furthermore, 367 desaturation events were recorded, with an average saturation of 92.5% and a minimum saturation of 72.5%. Thus, a severe form of SDB was diagnosed. The patient qualified for surgical treatment with the aim of restoring nasal patency and histopathologically verifying the presence of a soft-tissue mass located within the nasopharynx. The lesion was removed using Beckman's adenotome and histopathologically assessed to determine a diagnosis of nasopharyngeal chordoma. Microscopic examination revealed a lobulated tumor divided by fibrous septa, composed of vacuolated neoplastic cells in a myxoid stroma. The resection was not microscopically radical, therefore, additional diagnostic and oncological treatments were planned. However, the patient did not agree to the proposed treatment strategies. Six months after the primary surgical procedure, the patient underwent a follow-up imaging assessment. CT of the maxillofacial region with contrast revealed thickening of the posterior pharyngeal wall on the border of the nasopharynx and oropharynx, with greater enlargement on the left side (Fig. 1C). The thickness of the pre-spinal tissue at the C2 level had increased to ~13 mm. The described area was contrast-enhanced within 63–80 HU limits and it was identified that the lesion adhered to the longissimus capitis muscle, however, unambiguous features of its infiltration were not identified in the CT images. In addition, the neck lymph nodes were not enlarged and no pathological remodeling within the bony structures was identified. Magnetic resonance imaging (MRI) examination clarified the presence of a nodular structure outlined within the nasopharyngeal roof, situated further towards the left side and unevenly contrast enhanced (Fig. 1D). Again, surgical and oncological treatment strategies were proposed to the patient, however, the patient refused. Six months after the chordoma diagnosis, polysomnography was performed as a follow-up examination and a significant improvement was identified in the respiratory parameters. Only 35 respiratory incidents of desaturation were recorded, and no apneas were detected. Furthermore, the AHI was 6.4, the average saturation during examination was 95% and the minimum saturation was 81%.

Discussion

It is estimated that between 9 and 24% of the general population have SDB (8). Various risk factors for developing SDB exist, including obesity, the male gender, older age, a positive family history, hormonal disorders, tobacco smoke, alcohol consumption, maxillofacial region structural abnormalities and upper airway patency disorders. A recognized association exists between SDB and obesity, with SDB diagnosed in 50–77% of obese patients (9). The probability of SDB occurrence rises with the increase in the degree of obesity; in particular, the risk of sleep apnea syndrome increases by 10-fold among individuals with at least first-degree obesity (BMI, >30 kg/m2) (10). Furthermore, an obstructive form of SDB qualifying for surgical obesity treatment is diagnosed in 70–91% of pathologically obese patients (BMI, >40 kg/m2) (11–13). The type of fatty tissue distribution is of particular importance in the SDB pathogenesis of obese patients (14–16). Deposits of fatty tissue within the neck compress the walls of the pharynx from the outside, and fatty tissue infiltrates degenerate the neck muscles, impairing the ability of the muscles to support the upper airways; thus, patency is more easily impaired in obese patients, particularly in those with a high fat distribution in the neck (17).

Upper airway patency disorders resulting from structural abnormalities, which are the result of various pathologies within the head and neck, are important in the pathogenesis of SDB (18). Thorough investigation into upper airway patency at the oropharynx has identified a number of factors involved in oropharynx obstruction, including a lengthened soft palate, tongue and uvula hypertrophy, and palatine tonsil hypertrophy (19). However, the role of nose and nasopharynx patency in SDB pathogenesis (with the exception of in children, where adenoids are the predominant cause of SDB) has yet to be discussed (20).

The lower section of the upper airways, in contrast to the nasal cavity, larynx, trachea and bronchi level, does not have cartilaginous or osseous scaffolding to provide rigid support (21). Instead, stabilization at this level is predominantly provided by the pharynx, palate and tongue muscles. During inspiration, a partial or complete collapse and narrowing of the lumen of the airway occurs when the negative pressure in the airway is greater than the tension of the stabilizing muscles of the wall. As a consequence, OSA occurs (19–22). The pathologies that lead to nasal patency impairment cause a rise in negative pressure in the upper airways during inspiration (23), therefore, increasing the risk of obstructive apneas. Nasal patency disorders may result from numerous anatomical abnormalities and pathologies that make nasal ventilation difficult, such as deviation of the nasal septum, nasal polyps, inferior nasal turbinate hypertrophy, middle nasal turbinate pneumatization, posterior nares underdevelopment, neoplasms, granulomatous diseases, adenoid hypertrophy, meningocele, foreign bodies, post-operative and post-traumatic adhesions, and allergic and non-allergic rhinitis (20,22).

Various studies in the literature have indicated that nasal patency disorders should be treated as a potential risk factor for SDB development (24,25). For example, in a prospective study by Lofaso et al (26), it was stated that nasal patency disorders assessed on the basis of posterior rhinomanometry are independent risk factors for OSA development, although their impact was significantly weaker compared with the effect of obesity or facial bone abnormalities. By contrast, Young et al (27) did not identify a strong association between increased airway resistance at the level of the nasal cavity and SDB in the total population. In addition, the use of surgical treatment for nasal patency disorders as a treatment strategy for SDB is controversial, with contrary perspectives reported in the literature. Sériès et al (28) determined that surgical correction of nasal patency disorders is an effective method of SDB treatment, but only in patients who were not diagnosed with significant abnormalities of the facial bones. Isolated studies have described cases of upper airway neoplastic lesions, which predominantly manifest as nasal and nasopharyngeal obstruction, leading to SDB (29–31). Furthermore, Piccin and Sorrenti (29) described a retropharyngeal space lipoma with severe symptoms typical of SDB that completely subsided following surgical removal of the tumor.

The case described in the current study concerns a rare nasopharyngeal chordoma that manifested as a nasal obstruction, resulting in SDB. Chordomas are slow-growing malignant neoplasms originating from the remnants of the notochord, a primitive tissue of embryonic origin that is preserved outside of the axial skeleton. Chordomas develop in the midline of the body, most often in the sacrococcygeal area of the spine (50–60%), the skull base (25–30%), the cervical spine (~10%) and the thoracolumbar segment of the spine (~5%). Chordoma localization in the skull base is limited to the clivus, and casuistic cases are concerned with lesions developing outside of the bones as a soft-tissue mass in the nasopharynx (32,33). In addition, chordomas constitute only 0.2% of all nasopharyngeal neoplasms, therefore, diagnosis poses a significant challenge, and pre-surgical diagnostics based on a patient's clinical condition and imaging examinations do not typically coincide with the final histopathological diagnosis. Chordoma can develop at any age, however, it is predominantly diagnosed in adults. Lesions in the skull base typically occur in the third and fourth decade of life, while tumors of the sacrococcygeal area typically occur in the fifth and sixth decade (34). Furthermore, male individuals suffer from chordoma twice as often as females (35). Chordomas leading to distant metastasis to the lungs, liver, bones and lymph nodes have previously been described in the literature (36).

Nasal patency symptoms are dominant in tumors located within the nasopharynx. Imaging diagnostics are based on CT and MRI scans of the area occupied by the tumor, however, the two techniques provide non-specific images of the lesion (37). Chordomas are not chemotherapy-sensitive tumors, therefore, the typical treatment strategy is radical surgery. However, the localization of chordomas in the vicinity of nervous system structures makes negative tissues margins difficult or even impossible to obtain. In such cases, surgical resection should be complemented with post-operative radiotherapy. Efficient chordoma radiotherapy treatment requires the use of high-dose radiation (>60 Gy), which may damage sensitive tissue in the brain and optic nerve chiasm area. Promising alternatives include modern conformal radiotherapy techniques, intensity-modulated radiation therapy and proton beam therapy (38). Furthermore, combined treatment strategies provide good local control. It is estimated that the five-year survival rate of patients with chordomas of all localizations is ≤70% (39).

The nasopharyngeal chordoma described in the current study was incidentally diagnosed due to poor symptomatology. The chordoma was diagnosed during SDB diagnostics performed as a part of a research project of pathologically obese patients qualifying for bariatric surgery. A non-typical radiogram without features of adhering bone structure destruction and endoscopic images imitating nasopharyngeal lymphatic tissue hypertrophy were obtained, thus, the SDB diagnostics were not extended to incorporate neoplastic disease at the preliminary stage. A polysomnographic control examination, which was performed independently of oncological proceedings, revealed a significant improvement in various respiratory parameters following tumor removal; however, the BMI did not change, as the patient was not subjected to bariatric surgery. Thus, it is proposed that the obstruction of the nasopharynx by the tumor was the predominant cause of the SDB.

SDB is a common phenomenon in pathologically obese individuals and polysomnography should be the diagnostic gold standard in this group of patients. Although the predominant risk factor in SDB patients with a high BMI is the obesity itself, this does not prejudice the duty of additional laryngological diagnostics with the aim of excluding organic and anatomical causes of SDB.

Laryngological assessment of patients with SDB should be based on a detailed interview and physical examination, followed by an endoscopic examination of the upper airways. When necessary, this should be accompanied by a head and neck imaging examination.

In conclusion, nasopharyngeal chordoma is a rare type of slow-growing nasopharyngeal malignant neoplasm that may remain unnoticed for a long period of time. Due to its non-specific clinical presentation and, in a number of cases, a lack of radiological features consistent with infiltration of the nasopharyngeal bone structures, this neoplasm is often misdiagnosed as a benign lesion of the nasopharynx, such as an enlarged adenoids.

Acknowledgements

This study was supported by the EEA/Norway Grants (grant number POL/NOR/196258/2013.

References